Taken together, the significant expression of tumor-infiltrating immune cells, immunostimulators, immunoinhibitors, major histocompatibility complex molecules, among others in various cancers point to an association between changes in VSTM2L and disease prognosis and development. This evidence concerns the gene VSTM2L and cancer.